Jump to content



Recommended Posts

  • Replies 804
  • Created
  • Last Reply

Top Posters In This Topic

Looks like termilone is a long way from analysis as to being effective or commercially viable.


At the moment, trials as a barrier to termites does not even protect for 7 days, so unless they can come up with a rate that will provide even half a years protection, and a costing, I would not be very hopeful of the future of this product, or of BPOs ability to bring to and market before shareholders are unwilling to support the company on any further necessary cap raising, especially as directors show no support at these raisings.

Link to comment
Share on other sites

Buy 1.1c, sell 1.2c. A slow death spiral continuing. If they can raise further cash, at what price will it be at to entice investors. You can be certain that the price will follow. Looks like the SLA investment will sink with it.
Link to comment
Share on other sites

  • 4 weeks later...

Wow. On first read of announcement it seems that there will be quite a fight between BPO and SLA.


However, on further reading maybe it is BPO's way of coming to a re-negotiation of the Agreement.


Hard to believe there might be problems with ownership of patents/licensing.


BPO is not really in a financial position to be fighting via the courts.


Wouldn't mind a read of the Agreement.

Link to comment
Share on other sites

  • 4 weeks later...
  • 2 weeks later...

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

  • Create New...